We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GBFH:NASDAQGBank Financial Holdings Inc. Analysis

Data as of 2026-06-17 - not real-time

$30.06

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

GBank Financial Holdings (GBFH) is trading at $30.06, comfortably above its 20‑day SMA (≈$29.76) and 50‑day SMA (≈$29.17), suggesting short‑term momentum. The MACD histogram remains positive and the MACD line sits above its signal, signaling a bullish technical bias. RSI at 52 is neutral, indicating the stock is neither overbought nor oversold. However, the price still lags the 200‑day SMA (~$33.18), highlighting a longer‑term downtrend that could cap upside. Volatility is elevated at roughly 42% over the past 30 days, and the market’s Fear & Greed Index reads “Extreme Greed,” underscoring heightened speculative sentiment. On the fundamentals side, revenue grew modestly 4.3% YoY while operating margins sit near 34% and profit margins above 24%, reflecting a solid earnings engine.
The forward earnings estimate of $3.54 drives a forward P/E of about 8.5, dramatically cheaper than the trailing P/E of 24.6 and the industry average of 17.1, implying strong earnings upside. Yet a discounted cash‑flow model values the company near $9, and the current price is more than three times that figure, flagging significant overvaluation. The balance sheet is strong, with cash exceeding $108 M and zero net debt, providing a cushion against credit stress. The recent appointment of Jeffrey K. Newgard as President and CEO of GBank could enhance strategic execution and investor confidence. Analyst consensus is a “strong buy” with median price targets around $35, indicating expectations for further price appreciation. Considering the mix of bullish technical signals, robust profitability, and a pronounced valuation gap, the stock appears poised for short‑term upside but carries notable downside risk if the long‑term trend reasserts.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and positive histogram
  • Increasing volume supporting momentum
  • Price comfortably above 20‑day SMA and near support level

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward EPS growth yielding a low forward P/E
  • Strong operating and profit margins
  • New CEO appointment as a strategic catalyst

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Significant valuation gap versus DCF fair value
  • High 30‑day volatility and extreme greed sentiment
  • Sector headwinds for regional banks and long‑term downtrend

Key Metrics & Analysis

Financial Health

Revenue Growth4.30%
Profit Margin24.39%
P/E Ratio24.6
ROE11.31%
ROA1.38%
P/B Ratio2.6
Op. Cash Flow$5.3M
Industry P/E17.1

Technical Analysis

TrendNeutral
RSI52.0
Support$27.32
Resistance$32.99
MA 20$29.76
MA 50$29.17
MA 200$33.18
MACDBullish
VolumeIncreasing
Fear & Greed Index92.13

Valuation

Fair Value$9.02
Target Price$39.00
Upside/Downside29.74%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.75
Volatility41.83%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.